Informação sobre produto
- N-[2-[5-(aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methyl glycineCI 1031Fidexaban
- Zk-807834
- Bx-807834
- ZK-807191(diHCl)
- Pd-200022
- Ci-1031
- N-[(2-{[3-(diaminomethylidene)-6-oxocyclohexa-1,4-dien-1-yl]oxy}-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl)methyl]glycine
Fidexaban is a low molecular weight heparin with antithrombotic properties. It has been shown to be effective in preventing thrombosis, including pulmonary embolism and deep vein thrombosis, and for the treatment of coronary artery disease. Fidexaban is a competitive inhibitor of heparin that binds to the active site of serine proteases. The binding prevents these enzymes from cleaving the substrate and leads to an increase in soluble guanylate cyclase activity, which inhibits platelet aggregation and reduces blood clotting. Fidexaban also binds to proteins on the surface of red blood cells and inhibits platelet aggregation. This drug is classified as a low molecular weight heparin because it has a molecular weight of less than 5000 Da.
Propriedades químicas
Consulta técnica sobre: 3D-FF23284 Fidexaban
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.